Videos

Dr. Patrick Flume encourages clinicians to think a little differently when presented with a patient who has a chronic cough without an identifiable cause.

Patrick Flume, MD: Could a Persistent Cough be Bronchiectasis?

Bronchiectasis varies in presentation and appears to affect individuals from broad areas of the country. According to Dr. Patrick Flume, the task is to figure out what the best method of management is.

Patrick Flume, MD: Finding the Best Management for Bronchiectasis

Dr. Rocha discusses treatment options, overall safety, and patient populations undergoing surgery. 

Karolinne Rocha, MD: Advancements in Cataract, Refractive Surgery 

Dr. Temeia Martin talks about how her team identified the transition period as a major obstacle for patients with sickle cell disease and what her task force has implemented as a solution.

Temeia Martin, MD: Transitioning SCD Patients from Pediatric to Adult Care

Articles

From the struggle of obtaining insurance approvals to addressing the nationwide shortage of rheumatologists, Dr. Baker Frost talks about her experience treating patients with autoimmune disease. 

Deanna Baker Frost, MD, Addresses the Difficulties of Treating Autoimmune Disease

Dr. Brown discusses the most common conditions of patients treated for ocular trauma and highlights the range of performed procedures in the ED. 

Susannah Brown, MD: A Look Into Ocular Trauma

Elizabeth Mack, MD, MS, of MUSC joins MD Mag for a discussion on parents, trauma, vaccinations, and more in pediatric care.

DocTalk Tweet Chat "Parents and Physicians in Pediatric Care" Scheduled for July 31

Vancomycin 125 mg once or twice daily might help patients who are at the highest risk for recurrent infection.

Oral Vancomycin Lowers Risk for Recurrent C Difficile

There are 3 FDA-approved medications available to treat opioid use disorder, and different treatment approaches that can aid patients on the road to recovery.

Treating the Opioid Epidemic: Medications & Approaches

Added stigma further burdens the treatment of patients with opioid use disorder, but the medical community can do something about it.
 

Confronting Stigma in the Opioid Crisis

Founded in 1824 in Charleston, MUSC is home to the oldest medical school in the South as well as the state’s only integrated academic health sciences center, with a unique charge to serve the state through education, research and patient care. Each year, MUSC educates and trains more than 3,000 students and nearly 800 residents in six colleges: Dental Medicine, Graduate Studies, Health Professions, Medicine, Nursing and Pharmacy. MUSC brought in more than $327.6 million in biomedical research funds in fiscal year 2021, continuing to lead the state in obtaining federal and National Institutes of Health funding, with more than $220 million. For information on academic programs, visit musc.edu.

As the clinical health system of the Medical University of South Carolina, MUSC Health is dedicated to delivering the highest-quality and safe patient care while training generations of compassionate, competent health care providers to serve the people of South Carolina and beyond. Close to 25,000 care team members provide care for patients at 14 hospitals with approximately 2,500 beds and five additional hospital locations in development, more than 300 telehealth sites and nearly 750 care locations situated in the Lowcountry, Midlands, Pee Dee and Upstate regions of South Carolina. In 2021, for the seventh consecutive year, U.S. News & World Report named MUSC Health the No. 1 hospital in South Carolina. To learn more about clinical patient services, visit muschealth.org.
MUSC and its affiliates have collective annual budgets of $4.4 billion. The nearly 25,000 MUSC team members include world-class faculty, physicians, specialty providers and scientists who deliver groundbreaking education, research, technology and patient care.

Medical University of South Carolina

Latest News